CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
How Integrating IIoT with LIMS Can Enhance Lab Operations

How Integrating IIoT with LIMS Can Enhance Lab...

Aviana Rios, Director, Digital Technology, Viatris

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

Specialized Services: A New Paradigm in Therapeutics

Specialized Services: A New Paradigm in...

Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

Raising capital for early stage biotech start-ups

Raising capital for early stage biotech start-ups

Dr. John Kurek, Inverstment Manager and Dr. Peter Devine, CEO, Uniseed

How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?

How Will Digital Transformation Revolutionize...

Robert Peterson, Head Of Sales Health and Life Sciences Americas and Asia, BT - Health and Life Sciences

Managing Impacts of Technology Transformations in Pharmacovigilance

Managing Impacts of Technology Transformations...

Olga Minkov, Executive Director, Operations - Pharmacovigilance & Epi, Gilead Sciences

How a Clinical Focus Group and Electronic Medical Records Improved Post-Partum Outcomes

How a Clinical Focus Group and Electronic...

Michael Marino, SVP & Chief Medical Information Officer, Providence St. Joseph Health

Challenges and Opportunities for AI in Drug Discovery

Challenges and Opportunities for AI in Drug...

Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, and

Previous Next
How Integrating IIoT with LIMS Can Enhance Lab Operations

How Integrating IIoT with LIMS Can Enhance Lab Operations

Aviana Rios, Director, Digital Technology, Viatris

Re-imagining Learning in a Post-Pandemic World

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

Specialized Services: A New Paradigm in Therapeutics

Specialized Services: A New Paradigm in Therapeutics

Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories

Antibodies: The Building Blocks of Cures

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

Raising capital for early stage biotech start-ups

Raising capital for early stage biotech start-ups

Dr. John Kurek, Inverstment Manager and Dr. Peter Devine, CEO, Uniseed

How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?

How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?

Robert Peterson, Head Of Sales Health and Life Sciences Americas and Asia, BT - Health and Life Sciences

Managing Impacts of Technology Transformations in Pharmacovigilance

Managing Impacts of Technology Transformations in Pharmacovigilance

Olga Minkov, Executive Director, Operations - Pharmacovigilance & Epi, Gilead Sciences

How a Clinical Focus Group and Electronic Medical Records Improved Post-Partum Outcomes

How a Clinical Focus Group and Electronic Medical Records Improved Post-Partum Outcomes

Michael Marino, SVP & Chief Medical Information Officer, Providence St. Joseph Health

Challenges and Opportunities for AI in Drug Discovery

Challenges and Opportunities for AI in Drug Discovery

Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, and

Machine Learning in the Life Sciences

Eric Staib, Vice President, Compliance & Quality Management, Signant Health

Machine Learning in the Life Sciences

Recent Trends In The Startup Landscape

Al Sambar, General Partner, XRC Labs

Recent Trends In The Startup Landscape

Covid-19 as a Catalyst for Digital Transformation of Clinical Research: Are We There Yet?

Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, an AbbVie company, Dubai

Covid-19 as a Catalyst for Digital Transformation of Clinical Research: Are We There Yet?

Must Read

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

> <
  • Regulatory Services

    Top Vendors

    Current Issue
  • Clinical Lab Equipment

    Top Vendors

    Current Issue
  • Proteomics

    Top Vendors

    Current Issue

Read also

Managing Data in Digital Clinical Trials

Absci's Zero-Shot Generative AI Creates and Validates De Novo Antibodies

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

An Overview of Wholesalers' Roles in Complex Supply Chains

Fulcrum Therapeutics Announces CEO Transition

Consulting with life science experts has many benefits

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

A Patient-Focussed Therapeutic Measure Taking Up the Healthcare Space

De-risking the Preclinical Phase of Immunotherapy Drug Development

De-risking the Preclinical Phase of Immunotherapy Drug Development

Ralph Gareus, Director Business Development, The Jackson Laboratory
How we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company

How we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company

Marianthi Psacha, Global Head of Cell and & Gene Therapy, Santen

Medical Affairs Takes Centre Stage

Dr Sarah Tregenza PhD BSc(Hons), APAC Oncology Medical Affairs Director, Pierre Fabre
Medical Affairs Takes Centre Stage

Featured Vendor

ADNTRO: A Look Inside DNA to Prevent Disease

Orrbitt Creative Group: Unleashing the Creative Side of Pharma Marketing

CCRM: A Premier Incubator of CGT Companies

VaxTRIALS: Optimizing End-to-end Vaccine Trial Timeframes

General Bio: Ushering in an Era of Health and Well Aging

Atessia: Tailor-made Solutions for Pharmaceutical Regulatory Changes

Clinically Media: Setting a new Standard in Patient Recruitment and Retention for Clinical Trials

MDIMUNE: The Pioneer of Cell-Derived-Vesicle Therapeutics

How Can Artificial Intelligence Improve Clinical Trials?

Jorine Putter, Head of Advanced Analytics at Grünenthal and Yuri Martina, Head of Development at Grünenthal

How Can Artificial Intelligence Improve Clinical Trials?

Immunotherapy in Lung Cancer: building towards a patient-tailored future

James Holland, PhD. Senior Medical Writer, Ashfield Health

Immunotherapy in Lung Cancer: building towards a patient-tailored future

New Impella 5.5 Heart Pump Device Provides Potentially Life-Saving Treatment Option for Patients with Cardiogenic Shock

Mark Anderson, M.D., Chief of the Division of Cardiac Surgery and Cardiothoracic Surgeon at the Heart and Vascular Hospital at Hackensack University Medical Center and Hackensack Meridian Health.

New Impella 5.5 Heart Pump Device Provides Potentially Life-Saving Treatment Option for Patients with Cardiogenic Shock

Like a Tailored Suit: Producing Customized Viral Vectors that Respond to Market Demands

Margherita Neri, Vector Process Development Manager, and Giuliana Vallanti, Director, Development and Global R&D Cell and Gene, Anna Stornaiuolo, AGC Biologics

Like a Tailored Suit: Producing Customized Viral Vectors that Respond to Market Demands

Must Read

Efficiency-driven Digital Therapeutics Reshaping the European Healthcare

Trends Reshaping the Cell and Gene Therapies

Eric Strati to Join Gift of Life Biologics as Chief Executive Officer

Catalyst Pharmaceuticals Achieves U.S. Commercial Rights to FYCOMPA (Perampanel) CIII From Eisai Co.Ltd.

Key Advantages of Medical Writing

The Role of Pharmaceutical Wholesalers in the Drug Industry

Pharmaceutical Distribution: Balancing Availability and Speed with Shifting Models and Regulations

Top Trends in Pharma Wholesale Distribution

Challenges of the Pharmaceutical Wholesale And Distribution Industry

Thank you for Subscribing to Life Science Review Weekly Brief

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com